within Pharmacolibrary.Drugs.V_Various.V03A_AllOtherTherapeuticProducts.V03AF10_SodiumLevofolinate;
model SodiumLevofolinate 
   extends Pharmacolibrary.Drugs.ATC.V.V03AF10;

  annotation(Documentation(
    info ="<html><body><p>Sodium levofolinate, also known as levoleucovorin, is the active (S)-enantiomer of folinic acid. It is used as a chemoprotective agent to reduce the toxicity of methotrexate therapy and to enhance the efficacy of fluoropyrimidine-based chemotherapy. Approved for medical use, it is administered parenterally, often intravenously, as a rescue agent in cancer chemotherapy regimens.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic estimate for adults (no published human PK model located, see notes).</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end SodiumLevofolinate;
